From the quantification and validation of biomarkers to the integration of novel technology in bioanalytical workflows, as the year comes to a close we’re looking back on the bioanalytical highlights from 2018.
Researchers from the University of Queensland (Australia) have discovered a unique biomarker common to multiple cancers that has the potential to change the way early stage cancer is diagnosed.
Researchers fromat the University of British Columbia Okanagan (Kelowna, Canada) have developed a tool, using biosensors, to provide almost instant diagnosis of bacterial infections.
Collaboration in action: Nepali chemist receives 10 week bioanalytical training at three Dutch CRO’s
A Chemist and Quality Control Manager from a Nepali pharmaceutical company receives full training in bioanalytical method development and validation.
Researchers have developed a new nanoplasmonic biosensor device that precisely detects the presence of anticoagulants in blood samples.
A new mass spectrometry system with nanomechanical resonators has been utilized to accurately measure virus capsids above 100 MDa.
Researchers at the Brigham Young University (London, UK) have developed a non-invasive, nanoPOTS method for monitoring cancer by measuring the proteins in circulating tumor cells from the blood.
Researchers at the CEU Cardenal Herrera University (Valencia, Spain) have discovered the three most efficient types of salivary biomarkers for the early detection of oral cancer.
Thermo Fisher Scientific (MA, USA) has announced the launch of their latest FTIR spectrometer, the Nicolet iS20, with new Optical Engineer technology, to improve the accuracy and delivery of analysis of complex samples for scientists.
Read more about some of the latest news in these announcements from MilliporeSigma (MA, USA) and Thermo Fisher Scientific (MA, USA), at AAPS (4–7 November 2018; DC, USA).